These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24605557)

  • 61. Chasing the personalized medicine dream through biomarker validation in colorectal cancer.
    Patil H; Saxena SG; Barrow CJ; Kanwar JR; Kapat A; Kanwar RK
    Drug Discov Today; 2017 Jan; 22(1):111-119. PubMed ID: 27693431
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Atopic dermatitis phenotypes and the need for personalized medicine.
    Cabanillas B; Brehler AC; Novak N
    Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):309-315. PubMed ID: 28582322
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Personalized medicine and economic evaluation in oncology: all theory and no practice?
    Garattini L; Curto A; Freemantle N
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):733-8. PubMed ID: 26289733
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
    Tazawa Y
    Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Steps forward for cancer precision medicine.
    Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
    Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is precision medicine ready for use in breast cancer?
    Pusztai L
    Clin Adv Hematol Oncol; 2016 Dec; 14(12):964-966. PubMed ID: 28212357
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
    Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Personalized/Precision Medicine/Personalised Healthcare: the art of giving different names to the same thing?
    March R; Schott C
    Per Med; 2017 Nov; 14(6):463-466. PubMed ID: 29749854
    [No Abstract]   [Full Text] [Related]  

  • 70. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 71. The Promise of Precision Oncology.
    Sindzinski A
    J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 30053244
    [No Abstract]   [Full Text] [Related]  

  • 72. Next-Generation Sequencing Informatics: Challenges and Strategies for Implementation in a Clinical Environment.
    Roy S; LaFramboise WA; Nikiforov YE; Nikiforova MN; Routbort MJ; Pfeifer J; Nagarajan R; Carter AB; Pantanowitz L
    Arch Pathol Lab Med; 2016 Sep; 140(9):958-75. PubMed ID: 26901284
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Editorial of the Special Issue "Molecular Medicine Applications in Infectious Diseases: Latest Innovations".
    Hassan STS
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958882
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Theory and Application of Network Biology Toward Precision Medicine.
    Demchak B; Kreisberg JF; Fuxman Bass JI
    J Mol Biol; 2018 Sep; 430(18 Pt A):2873-2874. PubMed ID: 30030027
    [No Abstract]   [Full Text] [Related]  

  • 75. Personalized lab test models to quantify disease potentials in healthy individuals.
    Cohen NM; Schwartzman O; Jaschek R; Lifshitz A; Hoichman M; Balicer R; Shlush LI; Barbash G; Tanay A
    Nat Med; 2021 Sep; 27(9):1582-1591. PubMed ID: 34426707
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Using Big Data to Determine Reference Values for Laboratory Tests-Reply.
    Manrai AK; Patel CJ; Ioannidis JPA
    JAMA; 2018 Oct; 320(14):1496. PubMed ID: 30304422
    [No Abstract]   [Full Text] [Related]  

  • 77. Ethical issues in precision medicine.
    Jonsson JJ; Stefansdottir V
    Ann Clin Biochem; 2019 Nov; 56(6):628-629. PubMed ID: 31370674
    [No Abstract]   [Full Text] [Related]  

  • 78. Precision/personalized aneurysm treatment in era of increasing options.
    Bulsara KR
    Acta Neurochir (Wien); 2018 Oct; 160(10):1961. PubMed ID: 30109495
    [No Abstract]   [Full Text] [Related]  

  • 79. Editorial: Clinical epileptology entering the era of personalized medicine.
    Steriade C
    Curr Opin Neurol; 2022 Apr; 35(2):143-144. PubMed ID: 35232932
    [No Abstract]   [Full Text] [Related]  

  • 80. Tissue navigator, an important position in the Pathology laboratory in the Precision Medicine era.
    Tavora F; de Sousa JC
    ESMO Open; 2023 Oct; 8(5):101827. PubMed ID: 37757665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.